<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="have the following interests: This study received financial support and" exact="duloxetine" post="from Eli Lilly, Copenhagen Denmark ( https://www.eli-lilly.dk/), and AstraZeneca,"/>
 <result pre="Funding The authors acknowledge financial support and the receipt of" exact="duloxetine" post="from Eli Lilly, Copenhagen Denmark ( https://www.eli-lilly.dk/); The Danish"/>
 <result pre="therapy and sleep phase advance [7], bright light therapy and" exact="lithium" post="[8], pindolol [9], bright light therapy and transcranial magnetic"/>
 <result pre="sleep phase advance [7], bright light therapy and lithium [8]," exact="pindolol" post="[9], bright light therapy and transcranial magnetic stimulation [10]."/>
 <result pre="study started with a one-week run-in phase where medication with" exact="duloxetine" post="was begun and diurnal variation assessed. Then followed a"/>
 <result pre="continued with sleep time stabilisation, daily morning light therapy and" exact="duloxetine" post="60 mg daily dosage and patients in the exercise"/>
 <result pre="individual exercise program of at least 30 minutes duration and" exact="duloxetine" post="in a daily dosage of 60 mg. In this"/>
 <result pre="Medication Patient received a fixed daily dosage of 60 mg" exact="duloxetine" post="in the morning, begun at the run-in phase, a"/>
 <result pre="therapy) to exercise in major depressive disorder patients treated with" exact="duloxetine" post=". J Clin Psychiatry 73: 1234â€“ 1242. 23059149 2"/>
 <result pre=", et al. ( 2000) Total sleep deprivation combined with" exact="lithium" post="and light therapy in the treatment of bipolar depression:"/>
 <result pre="( 1999) Sustained antidepressant effect of sleep deprivation combined with" exact="pindolol" post="in bipolar depression. A placebo-controlled trial . Neuropsychopharmacol 20:"/>
</results>
